Matthew Scalo | executive |
Paul Diaz | executive |
Mark Verratti | executive |
Samraat Raha | executive |
Scott Leffler | executive |
Matthew Sykes | analyst |
Douglas Schenkel | analyst |
Daniel Brennan | analyst |
Puneet Souda | analyst |
Andrew Cooper | analyst |
Rachel Vatnsdal Olson | analyst |
Subhalaxmi Nambi | analyst |
Jacob Krahenbuhl | analyst |
Thank you for standing by, and welcome to Myriad Genetics First Quarter 2024 Earnings Conference Call. [Operator Instructions] I would now like to hand the call over to Matt Scalo. Please go ahead.
Thanks, Latif, and good afternoon, and welcome to the Myriad Genetics First Quarter 2024 Earnings Call.
During the call, we will review the financial results we released today, and afterwards, we will host a question-and-answer session.